The week in health tech, explained in plain English.Get the free newsletter →
October 26, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

Arkansas Hospital Furloughs 50, Cuts Pay in Bankruptcy

Ouachita County Medical Center in Camden, Arkansas has furloughed close to 50 employees and reduced salaries for remaining staff as it tries to meet budget constraints under Chapter 11 bankruptcy, CEO Glenda Harper told Becker's Hospital Review. The furloughs took effect July 24 and run through Sept. 25, hitting nurses, pharmacy, environmental services, dietary and maintenance workers.

The cuts illustrate the financial pressure squeezing rural and community hospitals, where thin margins, rising labor costs, and heavy reliance on Medicare and Medicaid leave little cushion. When cash runs short, staffing is the fastest lever to pull, and furloughs plus pay cuts are often a last effort to keep the doors open through a restructuring.

For patients in Camden, the risk is reduced access to care in a region with few alternatives. For hospital operators nationally, Ouachita County is another warning sign that the post-pandemic financial strain on small facilities has not eased, and that bankruptcy is increasingly a survival tactic rather than a final act.

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.